Updates in the Management of Multiple Myeloma

CME: 1.5

January 31, 2021
/ Print / Reprints /
| Share More
/ Text Size+

Target Audience

This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and navigators engaged in the care of patients with multiple myeloma. Other healthcare providers may also participate.

Program Overview

Multiple myeloma outcomes have been improving thanks to treatment advances and the availability of new medication classes. Oncology nurses play a critical role in multiple myeloma care and keeping up with nursing implications of new agents is key to helping patients achieve their therapeutic goals.

As treatment options and strategies in multiple myeloma (MM) rapidly evolve, oncology nursing professionals will continue to be challenged to manage patients with MM according to the most recent treatment recommendations. Additionally, new agents have adverse event profiles that differ from standard chemotherapy and require new strategies for monitoring and management. Therefore, oncology nursing professionals will benefit from continuing education that assists them in keeping up to date on changes in treatment combinations and sequencing of regimens, as well as enhances their skills managing medication-related adverse effects.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the role of new medications in the treatment of MM
  • Identify adverse events and related nursing management strategies with new medications and combinations used to treat MM
  • Determine supportive care needs of MM patients considering their medication regimen and co-morbidities
  • Outline strategies to reduce the risk of skeletal, thrombotic, and infectious complications in MM

Post a comment to this article